Skip to main content

Table 1 Binding of Art v 1-peptides and mono-substituted peptides of Art v 1 25-36 to HLA-DRB1*01:01 and HLA-DRB1*04:01

From: Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background

Peptide

Amino Acid sequence

aratio of IC50 of Art v 1-peptides/HA306-318

 
 

HLA-DR1

HLA-DR4

 

HA304-318

PKYVKQNTLKLAT

1

1

 

Art v 119-30

NKKCDKKCIEWE

>55032

>926

 

Art v 122-33

CDKKCIEWEKAQ

2016

756

 

Art v 126-36

KCIEWEKAQHGA

14

15

 

Ala-25

A CIEWEKAQHGA

9

21

 

Ala-26

KA IEWEKAGHGA

16

3

 

Ala-27

KCA EWEKAQHGA

2596

>926

p1

Ala-28

KCIA WEKAQHGA

6

11

p2

Ala-29

KCIEA EKAQHGA

69

14

p3

Ala-30

KCIEWA KAQHGA

6

28

p4

Ala-31

KCIEWEA AQHGA

17

17

p5

Gly-32

KCIEWEKG QHGA

63

149

p6

Ala-33

KCIEWEKAA HGA

11

31

p7

Ala-34

KCIEWEKAQA GA

8

17

p8

Ala-35

KCIEWEKAQHA A

5

5

p9

Gly-36

KCIEWEKAQHGG

74

242

 
  1. a Relative binding activity. Binding of peptides to HLA-DR1 and -DR4 molecules was assessed by competitive inhibition of the high affinity interaction of biotinylated-HA306-318 with HLA-DR1 and -DR4 as described in Methods. IC50 values were converted into relative activities (ratio between IC50 value and IC50 of HA306-318) to take into account the differences of sensitivity of the binding assays. The IC50 of HA306-318 was 1.8 nM for HLA-DR1 and 11 nM for -DR4.